These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 12429800)

  • 1. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression in human pituitary tumors.
    Vidal S; Kovacs K; Bell D; Horvath E; Scheithauer BW; Lloyd RV
    Cancer; 2003 Jun; 97(11):2814-21. PubMed ID: 12767095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The topoisomerase IIalpha expression correlates with survival in patients with advanced Hodgkin's lymphoma.
    Provencio M; Corbacho C; Salas C; Millan I; Espana P; Bonilla F; Ramon Cajal S
    Clin Cancer Res; 2003 Apr; 9(4):1406-11. PubMed ID: 12684412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase IIalpha in multiple myeloma: a marker of cell proliferation and not drug resistance.
    Wilson CS; Medeiros LJ; Lai R; Butch AW; McCourty A; Kelly K; Brynes RK
    Mod Pathol; 2001 Sep; 14(9):886-91. PubMed ID: 11557785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma.
    Watanuki A; Ohwada S; Fukusato T; Makita F; Yamada T; Kikuchi A; Morishita Y
    Anticancer Res; 2002; 22(2B):1113-9. PubMed ID: 12168909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
    Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
    Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvessel density in pituitary adenomas and carcinomas.
    Vidal S; Kovacs K; Horvath E; Scheithauer BW; Kuroki T; Lloyd RV
    Virchows Arch; 2001 Jun; 438(6):595-602. PubMed ID: 11469692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
    Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
    Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
    Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.
    Arpino G; Ciocca DR; Weiss H; Allred DC; Daguerre P; Vargas-Roig L; Leuzzi M; Gago F; Elledge R; Mohsin SK
    Breast Cancer Res Treat; 2005 Jul; 92(1):69-75. PubMed ID: 15980993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R; Alanen K; Syrjänen S
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.
    Berney DM; Stankiewicz E; Adlan AM; Kudahetti S; Biedrzycki OJ; Hadway P; Watkin N; Corbishley C
    BJU Int; 2008 Sep; 102(8):1040-4. PubMed ID: 18489530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.
    Järvinen TA; Kononen J; Pelto-Huikko M; Isola J
    Am J Pathol; 1996 Jun; 148(6):2073-82. PubMed ID: 8669491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.